Role of hypertension in the metabolic syndrome: Who is affected? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-11

AUTHORS

Gladys Velarde, Bradford C. Berk

ABSTRACT

Hypertension is one of the components of the metabolic syndrome. The “deadly quartet,” as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks). More... »

PAGES

418-426

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x

DOI

http://dx.doi.org/10.1007/s11906-005-0036-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051822855

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16386197


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velarde", 
        "givenName": "Gladys", 
        "id": "sg:person.016455534201.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016455534201.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berk", 
        "givenName": "Bradford C.", 
        "id": "sg:person.012523312277.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012523312277.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00402173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052589861", 
          "https://doi.org/10.1007/bf00402173"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-11", 
    "datePublishedReg": "2005-11-01", 
    "description": "Hypertension is one of the components of the metabolic syndrome. The \u201cdeadly quartet,\u201d as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks).", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11906-005-0036-x", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021183", 
        "issn": [
          "1522-6417", 
          "1534-3111"
        ], 
        "name": "Current Hypertension Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "role of hypertension", 
      "metabolic syndrome", 
      "insulin resistance", 
      "certain ethnic groups", 
      "deadly quartet", 
      "atherogenic dyslipidemia", 
      "abdominal obesity", 
      "high prevalence", 
      "obesity epidemic", 
      "syndrome", 
      "ethnic groups", 
      "hypertension", 
      "obesity", 
      "dyslipidemia", 
      "complex association", 
      "hyperglycemia", 
      "group", 
      "prevalence", 
      "United States", 
      "epidemic", 
      "association", 
      "role", 
      "relative contribution", 
      "population", 
      "significance", 
      "resistance", 
      "disproportionate contribution", 
      "people", 
      "large part", 
      "constituents", 
      "part", 
      "components", 
      "future", 
      "contribution", 
      "article", 
      "variation", 
      "state", 
      "quartet"
    ], 
    "name": "Role of hypertension in the metabolic syndrome: Who is affected?", 
    "pagination": "418-426", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051822855"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11906-005-0036-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16386197"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11906-005-0036-x", 
      "https://app.dimensions.ai/details/publication/pub.1051822855"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_404.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11906-005-0036-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-005-0036-x'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      21 PREDICATES      71 URIs      62 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11906-005-0036-x schema:about N0e4c7875c8ca4d508f72ae3d1a6c0c59
2 N3feb6e931bf743f6a535518908bcbe6b
3 N424975246cf14e8389c9fb1bc8a0422b
4 N9e462d41ef454f3e9f849a12e9c59a22
5 Na9be06c917e04045870701c070bd83a7
6 Nafaffd3ef231419ab732274748339877
7 Nd686bbfbf8754f0c85c1e6baf45d58aa
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author Nf54ad075d13d438c96f475a2ec080c8e
11 schema:citation sg:pub.10.1007/bf00402173
12 schema:datePublished 2005-11
13 schema:datePublishedReg 2005-11-01
14 schema:description Hypertension is one of the components of the metabolic syndrome. The “deadly quartet,” as this syndrome is often referred to, also includes atherogenic dyslipidemia; hyperglycemia and/or insulin resistance (IR); and abdominal obesity. More than 47 million people in the United States have the metabolic syndrome, with a higher prevalence in certain ethnic groups. This is expected to rise significantly in the future, in large part due to the obesity epidemic. The relative contribution of each of the constituents of this syndrome varies according to the population in which it occurs, but the significance of these variations is not known. In this article, we review the role of hypertension in the metabolic syndrome, its complex association with obesity and IR, and its disproportionate contribution to the syndrome in certain ethnic groups (specifically US blacks).
15 schema:genre article
16 schema:isAccessibleForFree false
17 schema:isPartOf Nbb96f6a2031743808ceb04b51c5dfd19
18 Nf85bd36956ac4d4fab2218ded1742792
19 sg:journal.1021183
20 schema:keywords United States
21 abdominal obesity
22 article
23 association
24 atherogenic dyslipidemia
25 certain ethnic groups
26 complex association
27 components
28 constituents
29 contribution
30 deadly quartet
31 disproportionate contribution
32 dyslipidemia
33 epidemic
34 ethnic groups
35 future
36 group
37 high prevalence
38 hyperglycemia
39 hypertension
40 insulin resistance
41 large part
42 metabolic syndrome
43 obesity
44 obesity epidemic
45 part
46 people
47 population
48 prevalence
49 quartet
50 relative contribution
51 resistance
52 role
53 role of hypertension
54 significance
55 state
56 syndrome
57 variation
58 schema:name Role of hypertension in the metabolic syndrome: Who is affected?
59 schema:pagination 418-426
60 schema:productId N02d8e5336b9447b78d5ea93e1c40c454
61 N99ced2ac67ac492f8e92512950a693d8
62 Nfa39182d8b0145488a76657f0b5482bc
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051822855
64 https://doi.org/10.1007/s11906-005-0036-x
65 schema:sdDatePublished 2022-12-01T06:25
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher N57c5532788e0492f9ade0ae5e91a7440
68 schema:url https://doi.org/10.1007/s11906-005-0036-x
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N02d8e5336b9447b78d5ea93e1c40c454 schema:name dimensions_id
73 schema:value pub.1051822855
74 rdf:type schema:PropertyValue
75 N0e4c7875c8ca4d508f72ae3d1a6c0c59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 N312ca5c1b48d4f37b59a2d7430c9e68e rdf:first sg:person.012523312277.63
79 rdf:rest rdf:nil
80 N3feb6e931bf743f6a535518908bcbe6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Risk Factors
82 rdf:type schema:DefinedTerm
83 N424975246cf14e8389c9fb1bc8a0422b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Metabolic Syndrome
85 rdf:type schema:DefinedTerm
86 N57c5532788e0492f9ade0ae5e91a7440 schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N99ced2ac67ac492f8e92512950a693d8 schema:name pubmed_id
89 schema:value 16386197
90 rdf:type schema:PropertyValue
91 N9e462d41ef454f3e9f849a12e9c59a22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name United States
93 rdf:type schema:DefinedTerm
94 Na9be06c917e04045870701c070bd83a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Lipids
96 rdf:type schema:DefinedTerm
97 Nafaffd3ef231419ab732274748339877 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Incidence
99 rdf:type schema:DefinedTerm
100 Nbb96f6a2031743808ceb04b51c5dfd19 schema:volumeNumber 7
101 rdf:type schema:PublicationVolume
102 Nd686bbfbf8754f0c85c1e6baf45d58aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Hypertension
104 rdf:type schema:DefinedTerm
105 Nf54ad075d13d438c96f475a2ec080c8e rdf:first sg:person.016455534201.95
106 rdf:rest N312ca5c1b48d4f37b59a2d7430c9e68e
107 Nf85bd36956ac4d4fab2218ded1742792 schema:issueNumber 6
108 rdf:type schema:PublicationIssue
109 Nfa39182d8b0145488a76657f0b5482bc schema:name doi
110 schema:value 10.1007/s11906-005-0036-x
111 rdf:type schema:PropertyValue
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
116 schema:name Clinical Sciences
117 rdf:type schema:DefinedTerm
118 sg:journal.1021183 schema:issn 1522-6417
119 1534-3111
120 schema:name Current Hypertension Reports
121 schema:publisher Springer Nature
122 rdf:type schema:Periodical
123 sg:person.012523312277.63 schema:affiliation grid-institutes:grid.16416.34
124 schema:familyName Berk
125 schema:givenName Bradford C.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012523312277.63
127 rdf:type schema:Person
128 sg:person.016455534201.95 schema:affiliation grid-institutes:grid.16416.34
129 schema:familyName Velarde
130 schema:givenName Gladys
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016455534201.95
132 rdf:type schema:Person
133 sg:pub.10.1007/bf00402173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052589861
134 https://doi.org/10.1007/bf00402173
135 rdf:type schema:CreativeWork
136 grid-institutes:grid.16416.34 schema:alternateName Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA
137 schema:name Cardiology Division, University of Rochester, Box 679, 14642, Rochester, NY, USA
138 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...